Back To CBEHx
Login

About Us

What we learn today shapes who we become tomorrow.

As seen in

F2
F3
CPD
LPIAwards22_Startup_finalist
CBC

Accelerate Online Learning

CBEHx is a platform driven by a commitment to accelerate online learning across advanced STEM disciplines.

Stay Informed with the Latest Scientific Advancements

Our carefully curated programmes and expert-developed learning resources are designed to keep you aligned with current scientific progress, technological innovations, and significant breakthrough discoveries.

High-Quality Scientific Learning

Our team comprises experienced academics, researchers, and industry specialists who bring extensive domain expertise to each course. We apply rigorous scientific principles and continually refine our content to ensure a relevant, impactful, and intellectually stimulating learning experience.

Strengthen Your Professional Credentials With CPD Accreditation

All our courses are CPD-accredited, providing you with a globally recognised certificate upon successful completion. This ensures that your learning contributes directly to your professional development and supports your scientific career progression.

World-class learning

Experience high-quality learning wherever you are.

CBEHx delivers high-quality scientific education to students, professionals, and organisations worldwide. Our courses are designed with clarity, flexibility, and convenience in mind, making it easy to learn on your schedule.

Through a combination of expert-developed content and interactive media, we provide a structured and impactful learning experience that supports your professional development.

Career-oriented learning

Our online courses are designed to support your career growth and help you stay updated with the latest scientific discoveries and breakthroughs.

Our Core Values

CBEHx believes that world-class teaching and expertise extend far beyond traditional classrooms.

We embrace innovation to enhance the efficiency, productivity, and overall performance of our team.

We build strong partnerships with institutions and organisations to expand opportunities and impact.

We develop programmes and learning materials that deliver meaningful value to our learners.

We prioritise a friendly, responsive experience and actively value learner feedback.

We foster a supportive and collaborative environment where teamwork and shared ideas thrive.

We promote a healthy, respectful, and encouraging workplace for all employees.

Our Team

Our team comprises highly qualified experts from diverse countries, each bringing several years of research and technical experience in their respective fields.

Martina Fabricci, MSc, MBA

Founder

Dr. Henrique S. Fernandes

Scientific & Medical Illustrator

Dr. Justine Braguy

Scientific & Medical Illustrator

Dr. Amrita Sarkar

Senior Scientific Writer

John Ademiluyi, B.Eng.

Graphic Designer

Dr. Christos Evangelou

Instructor

Dr. Corrado Minetti

Instructor

Dr. Alison Monroe

Instructor

Dr. Illida Nawi

Instructor

Dr. Hesham Gibriel

Instructor

Dr. Sherif Idriss

Instructor

Dr. James Marchant

Instructor

Dr. Alice Hamilton

Instructor

Dr. Alice Arcourt

Instructor

Dr. Lucie Vondráková

Instructor

Dr. María Banqueri López

Instructor

Dr. Mai Shafei

Instructor

Dr. Eléonore Fox

Instructor

Dr. Matthias Schröder

Instructor

Dr. Roushanak Rahmat

Instructor

Dr. Sterling Ramroach

Instructor

Dr. Veronica Hughes

Instructor

Dr. Vytautas Nastajus

Instructor

More About Cbehx

Accredited Program

CBEHx For Business

CBEHx For School

Martina Fabricci, MSc, MBA

Martina Fabricci, MSc, MBA, is a biotechnology leader with a strong scientific background and experience in biotechnology investment. She is internationally recognised for advancing gender equity and supporting inclusive, high-quality STEM education.

Her achievements include the Woman Who Achieves Award for Start-Up of the Year and the Woman Business Award for Innovation. She was also a finalist for Young Business Person of the Year at the SME National Business Awards and has received recognition from the Great British Entrepreneur Awards and the Wales StartUp Awards for MedTech Start-Up of the Year.

Martina serves on the NCFE Technical Education Advisory Board for Level 3 Technical Qualifications in Science. She is also pursuing a PhD in Bioethics at Universidad Católica de Valencia, researching the ethical implications of genetic engineering and CRISPR-based technologies.

Dr. Henrique S. Fernandes

Henrique has a Ph.D. in computational and theoretical chemistry from the University of Porto in Portugal. He studies enzymatic mechanism using computational methodologies to obtain complete descriptions of catalytic mechanisms with atomistic level of detail. These techniques provide valuable insights for the rational drug design and enzyme engineering. He has also more than 5 years of experience in software development and scientific illustration and animation. 

Dr. Justine Braguy

Dr. Justine Braguy holds a PhD in Biotechnology and Plant Science, a BSc in Chemistry, Physics, and Mathematics, and a Master’s in Biotechnology specialized in Synthetic Biology. Her research focuses on the role of strigolactones in plant development and their function as host-recognition signals used by the parasitic plant Striga. She investigates these processes through the study of CRISPR-mediated genome-engineered rice. Besides her research, she help researchers and companies to promote science to a broader audience using visuals.

Dr. Amrita Sarkar

PhD in Chemical Sciences from IISER-K India, with postdoctoral research experience in Chemical Biology from the University of Manchester. The research work involved development of glycan arrays for high-throughput screening of pathogens and biomarker discovery. Thereafter, Amrita have worked at Mylan Laboratories Ltd as an assistant manager in the development of parenterals.

John Ademiluyi, B.Eng

John graduated from the faculty of Engineering and Technology in University of Ilorin. He is a passionate self-taught graphic designer with the passion and enthusiasm for his work which has shone through, working locally and internationally, in the design and advertising industry. He works hard to combine marketing talent, exceptional design, and technology with outstanding customer service to build long-term partnerships, deliver value, and evolve with brands. He is an expatriate in business branding, motion graphics, corporate brand identity using a graphic-analytic approach to generate solutions through creative means.

Dr. Christos Evangelou

Ph.D. in Cancer Biology, Division of Molecular and Clinical Cancer Sciences, University of Manchester, UK. Areas of expertise include cancer immunology, melanoma research, cancer immunotherapy, and mechanisms of immunotherapy resistance. During my Ph.D. research, I studied the role of chronic inflammation and cytokine IFN-gamma in adaptation and immunotherapy resistance in melanoma. By integrating high-throughput transcriptomic analyses and employing various cancer cell lines and animal models, I have developed methods to predict response to immunotherapy in melanoma patients. During my research, I have used the CRISPR/Cas9 system to knockout genes in human and mouse cell lines to assess the role of certain genes in immunotherapy resistance in melanoma.

Dr. Corrado Minetti

Corrado holds a Ph.D. in molecular epidemiology from Liverpool University, U.K. He trained and conducted research in parasitology and medical entomology at the Liverpool School of Tropical Medicine. He developed strong expertise in the epidemiology and molecular diagnostics of parasitic and vector-borne infections, both in the lab and in the field in developing countries. He also has a strong interest in public health microbiology training, medical education, and science communication.

Dr. Alison Monroe

Alison is a marine biologist with a Ph.D. in marine science from the King Abdullah University of Science and Technology in Saudi Arabia. She studies the effect of climate change on marine organisms, specifically those that live in threatened coral reef ecosystems. Her recent work uses molecular tools such as transcriptomics and proteomics to research how fish might acclimate to future climate scenarios. She spent much of the past 6 years exploring the beautiful and diverse coral reefs of Saudi Arabia and helped document one of the first mass coral bleaching events in the Red Sea.

Dr. Illida Nawi

Illida has always been passionate about sharing her knowledge and mentoring students with their research projects. She obtained her degree in Biomedical Engineering (concentration in Biomaterials and Tissue Engineering) from the Case Western Reserve University, USA. After graduating, she pursued her studies in the design and validation of a novel-designed mechanical cell bioreactor and later earned M.Sc. in Biomedical Engineering from the University of Malaya, Malaysia. This is also where she acquired four years of teaching experience. Besides teaching, Illida also gained experience in designing laboratory modules and supervising and training undergraduate and postgraduate students in research technical skills. Later on, she moved to Manchester where she was awarded her Ph.D. from the University of Manchester for her research in regenerating cartilage in peptide hydrogels.

Dr. Hesham Gibriel

Ph.D. in Bioinformatics and Comparative Genomics from the University of Wageningen, The Netherlands. Experienced in Bioinformatics, Comparative Genomics, Comparative Patho-Genomics, Evolutionary Genomics, Host-Microbe Interaction, and Next-Generation-Sequencing (NGS).

Dr. Sherif Idriss

Sherif Idriss holds a Ph.D. in Neuroscience from the University of Lübeck, Germany, and an M.Sc. in Pharmacology from the University of Oxford, UK. During his doctoral research, he investigated the role of astrocytes in energy homeostasis and obesity, and developed novel methods for primary astrocyte culture. His work has been published in leading scientific journals, including Frontiers and Neuropsychopharmacology. Following his Ph.D., Sherif conducted postdoctoral research at the University of Bern, Switzerland, focusing on innovative therapeutic approaches for multiple sclerosis. His expertise spans neuroscience, pharmacology, and longevity biotechnology, and he has served as both a research scientist and CEO of multiple companies developing therapeutics for age-related conditions.

Dr. James Marchant

Ph.D. in Cardiac Physiology at the University of British Columbia. Investigating the role of the funny current in cardiac pacemaking and thermal tolerance in zebrafish using CRISPR genome editing technology.

Dr. Alice Hamilton

Dr. Alice Hamilton gained a 1st class BSc in Biomedical Sciences in 2015 from the University of Dundee. She then joined the William Harvey Institute Queen Mary University of London where in 2016 she gained a M.Res. in Inflammation: Cellular and Vascular Aspects and in 2020 she gained a Ph.D. in cardiovascular pathophysiology. Her doctoral thesis was titled ‘The Effect of Social Isolation on the Immune System’.

Dr. Alice Arcourt

Alice holds a Ph.D. in Neuropharmacology from Heidelberg University, Germany. During her Ph.D., she mainly studied the contribution and specificity of primary sensory neurons involved in acute pain signalling. After her Ph.D., she moved to London and focused on neurodevelopment at King’s College London. She developed strong expertise in neurophysiology, optogenetics, immunohistochemistry, and animal behaviour. Her work has been published in peer-reviewed scientific journals including Neuron, a well-established journal in the field of neuroscience.

Dr. Lucie Vondrakova

Ph.D. in Microbiology, University of Chemistry and Technology, Czech Republic. During and after her Ph.D., she participated in projects on microbial interactions with nanofibers, biofilm formation, and quorum sensing. Her major research concerned human pathogens Campylobacter spp. She developed protocols of molecular-genetic techniques for their identification, quantification, and phenotype and genotype characterisation. She focused on determining the limits of such methods including the issue of eliminating signals coming from dead cells, and how the mode of death influences results. She has strong expertise in microbiology and molecular genetics and following the internship in Vienna also strong interest in bioinformatics, and microbiomes.

Dr. María Banqueri Lopez

Dr. María Banqueri majored in Psychology at Granada University in 2013 and completed her M.Sc. in Cognitive Neuroscience in 2014. She conducted a Ph.D. at Oviedo University and an internship at Roslin Institute (Edinburgh University) about the psychobiological effects of early stress, during these four years she lectured at the Psychology faculty. In 2019 she moved to Warsaw to work as a postdoc in Molecular Neurobiology at Nencki Institute where she is finishing a project about the microglial role in major depressive disorders. During this last postdoc, she collaborated with La Sapienza University in Rome. She has published 11 scientific papers and 5 book chapters and shared scientific results in meetings and congresses more than 20 times.

Dr. Mai Shafei

Mai holds a Ph.D. in Cancer Metabolism from the University of the West of England, UK. Her Ph.D. focused on dysregulated cell metabolism in particular the role of branched-chain aminotransferase proteins in the progression of breast cancer. Her work has been published in peer-reviewed scientific journals including Oncotarget. After her Ph.D., she moved to Sheffield for a post-doctoral research position at the University of Sheffield investigating mechanisms by which epithelial tissues shape and polarize using the mammary gland as a model system. She has developed strong expertise in biochemistry, breast cancer, cell biology, and cell signalling pathways.

Dr. Eléonore Fox

Eléonore holds a Ph.D. in Medicine from the University of Cambridge. Her doctoral research focussed on respiratory diseases and intensive care. She has recently conducted a clinical research project on COVID-19 to analyse how the virus affects various types of immune cells in human blood. Prior to her completing her Ph.D., Eléonore has worked in cancer research for 4 years, both at the Dana Farber Cancer Institute of Harvard University and the Rosalind and Goodman Research Center at McGill University. She also has experience of working in a pharmacological company, having worked for the Global Research and Development Department of Pfizer.

Dr. Matthias Schröder

Ph.D. in Immunology at the Division of Immunopharmacology of the University Clinic of Frankfurt am Main. Involved in basic and applied research for immunological interventions to treat cancer for 13 years. Matthias used a high-throughput CRISPR/Cas9 approach to generate a library of knockout cells that could be differentiated into immunosuppressive cells to investigate the potential loss of function situations. Currently involved in the development of fusion proteins to activate receptors of the TNF-superfamily (CD40, CD27, etc.) at a small German Biotech company as Head of Assay Development.

Dr. Roushanak Rahmat

Dr. Roushanak Rahmat is an AI research scientist with research interests in medical imaging and cancer research. She was working on deep learning modeling for early detection of lung cancer at the Institute of Cancer Research (ICR), London. Before joining ICR, she was researching at the department of Neurosurgery, University of Cambridge, and the School of Computer Science of St. Andrews University. She obtained her Ph.D. in Electrical, Electronics, and Computer Engineering at Heriot-Watt University.

Dr. Sterling Ramroach

Sterling has a Ph.D. in Machine Learning from The University of the West Indies. He moved to London after his Ph.D. to pursue a Computer Vision Researcher position in the industry. His Ph.D. research focused on accelerating machine learning techniques with parallel processing and applying it to bioinformatics. His work is published in peer-reviewed scientific journals including Molecular Omics, Expert Systems with Application, and BMJ Innovations.

Dr. Veronica Hughes

Veronica Hughes received her Ph.D. in medical science from the University of Florida. Her primary interest was cancer metastasis, dysregulation of the tumour microenvironment, and analysis of clinical trial design. Additionally, she engaged in the development of novel small animal models.

Dr. Vytautas Nastajus

Vytautas holds MSc and Ph.D. in Cognitive Psychology from the University of Hull and Bishop Grosseteste University. His main interest lies in human cognition and memory, and how technology such as virtual reality can be employed to help research those subjects. The majority of his research involves programming and creating custom virtual environments which he uses to obtain the needed behavioural data.